Inspiring Science. Fueling Progress. Revolutionizing Care. – CPR24
Researchers are harnessing knowledge of the cellular and molecular underpinnings of cancer initiation and progression to develop safer and more effective treatments for patients.
Researchers are harnessing knowledge of the cellular and molecular underpinnings of cancer initiation and progression to develop safer and more effective treatments for patients.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.
Treatment with APR-1051 appears safe and well tolerated in patients with advanced solid tumors and select cancer-associated gene alterations.
A list of current APEx®facilities.
In a study presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, held October 23–25, researchers showed that a…
Dr. Supriya Chopra and Dr. Remi Nout on BIOEMBRACE
A mathematical puzzle fascinated Susan Ellenberg as a child. John is twice Mary’s age when John was Mary’s age. When Mary will be John’s age,…
Hear Alan P. Venook, MD, discuss recent updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for gastrointestinal cancers.
Jairam Krishnamurthy, MD, FACP, discusses the selective use of CDK4/6 inhibitors after prior progression on these agents in patients with breast cancer.
An abstract is unavailable.